An estimated two billion people lack the medicines they need. The 2016 Access to Medicines Index analyzes pharmaceutical companies’ efforts to improve access to medicines, vaccines and diagnostics for low- and middle-income countries.

As 2016 has come to a close, our team at the Coalition against Typhoid would like to take a moment to reflect on this busy year. It was a year that illustrated, more clearly than ever, that typhoid is a continuing and major threat to millions around the world. Over the course of 2016, an estimated 21 million people – most of them children – suffered from typhoid. Of these, 220,000 died of the disease. We saw typhoid outbreaks in Malawi, Fiji, Zimbabwe and other countries. In endemic countries like India and Nepal, the monsoon season worsened the impact of this disease. In 2016, typhoid struck at ordinary places like schools and weddings, and also at the most vulnerable places, such as refugee camps, reminding us that this disease doesn’t discriminate.

Dr. Ben Anyene has the daunting job of helping the Nigerian government find ways to pay for the immunization of the 5.3 million children born in the country each year. Dr.

It takes more than a vaccine to make a successful immunization program. This World Immunization Week, we are taking a look at some of the factors that contribute to effective immunization programs.

By the Dengue Vaccine Initiative

By Dr. Jon Andrus, Executive Vice President of the Sabin Vaccine Institute and Director of the Vaccine Advocacy and Education Program

For many people throughout the world, the bite of a mosquito is nothing more than a common annoyance. But for individuals living in dengue endemic countries such an annoyance can quickly turn into a life threatening condition.
Today, Sabin President Dr. Peter Hotez contributed a story to Foreign Policy about how little known neglected tropical diseases (NTDs) are wreaking havoc in some of the world's wealthiest nations. This and other stories in today's News Roundup.

Pages